ExodusPoint Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,783
| Closed | -$1.67M | – | 1717 |
|
|
2023
Q3 | $1.67M | Buy |
27,783
+6,473
| +30% | +$388K | 0.02% | 700 |
|
|
2023
Q2 | $1.54M | Buy |
+21,310
| New | +$1.54M | 0.01% | 835 |
|
|
2023
Q1 | – | Sell |
-18,063
| Closed | -$1.21M | – | 1870 |
|
|
2022
Q4 | $1.21M | Buy |
18,063
+9,019
| +100% | +$603K | 0.02% | 844 |
|
|
2022
Q3 | $486K | Buy |
+9,044
| New | +$486K | 0.01% | 1349 |
|
|
2021
Q2 | – | Sell |
-3,687
| Closed | -$351K | – | 2522 |
|
|
2021
Q1 | $351K | Sell |
3,687
-6,195
| -63% | -$590K | 0.01% | 1521 |
|
|
2020
Q4 | $613K | Buy |
9,882
+4,573
| +86% | +$284K | 0.01% | 1055 |
|
|
2020
Q3 | $316K | Sell |
5,309
-10,322
| -66% | -$614K | 0.01% | 1199 |
|
|
2020
Q2 | $1.09M | Buy |
+15,631
| New | +$1.09M | 0.03% | 681 |
|